Novartis to assess biologics with micro-sugar-needle delivery tech
Novartis has partnered with Google-backed Rani Therapeutics to assess an oral platform which delivers biologics through the intestinal wall using needles made of sugar.
Archives for May 26, 2015
Catalent and Lonza's Imbruvica contracts safe says AbbVie, post $21bn acq
AbbVie has closed the acquisition of Pharmacyclics and confirms it will continue to outsource manufacture the oncology drug Imbruvica.
Lonza set to get commercial Adva-27a contract if cancer drug is approved
Lonza shipped a sample batch of a drug for resistant cancers this week and is set produce commercial supplies if the Phase I candidate goes on to be approved says Sunshine Biopharma.
April US chemical output for pharma down says ACC; SOCMA welcomes R&D tax credit move
US production of chemicals for the drug industry fell in April according to data released days after renewed calls for permanent tax breaks to help American manufacturers compete globally.
LabCorp outlines near-term goals following Covance integration
With the integration of Covance moving along steadily, Dave King, chairman and CEO of LabCorp, told investors last week at the UBS Healthcare Conference that LabCorp is ramping up a series of initiatives that will lead to $300m (€276m) in new revenue...
Roundup of recent top CRO/CMO news
From new service offerings to manufacturing deals to more formal strategic partnerships, the world of contract research and manufacturing organizations has been busy as of late. Here’s a roundup of some of the deals and new offerings:
Merck Millipore nabs Singulex’s protein detection technology
Merck Millipore has entered an agreement whereby it will control and manage the Singulex Life Science Research business, which offers a technology that can provide ultra-sensitive protein detection.